复方苦参注射液在晚期恶性肿瘤患者姑息治疗中的作用

目的:探讨复方苦参注射液对晚期恶性肿瘤患者姑息治疗的近期疗效和毒副作用。方法:对45例晚期恶性肿瘤患者,采用复方苦参注射液20ml 0.9%N.S.或5%G.S.250ml静脉滴注,每日1次,3周为一疗程,连用2疗程～3疗程。结果:近期疗效:有效率4.4%,稳定率68.9%,临床受益率73.3%。止痛疗效:CR18.0%、PR23.1%、MR28.2%、NR30.8%。KPS评分:77.8%的患者有提高,提高10分者22.2%、提高20分及以上者55.6%,提高30分及以上者11.1%。除2例在输液时血管有刺激性不适外,几乎无毒副反应。结论:复方苦参注射液有一定的抗癌止痛作用,能提高患者生活质量,而又无明显毒副作用,在晚期乃至终末期恶性肿瘤患者姑息治疗中有独特治疗作用。     

电感耦合等离子体质谱测定黄芪注射液中砷、铅和镉

目的 建立电感耦合等离子体质谱快速测定黄芪注射液中铅、砷和镉的分析方法.方法 样品经过微波消解,以锗、铟、铋作为内标,以茶叶标准物质作为质控,采用ICP-MS测定上述3种元素.结果 3种元素在0.5 ng·mL-1～50 ng·mL-1浓度范围内线性良好,r值均大于0.999 5,回收率为91.5%~102.6%,RSD均小于4.7%.结论 本方法简单、快速,结果准确可靠,适用于黄芪注射液中上述3种元素的测定.     

药物洗脱支架在后循环动脉狭窄治疗中的应用

目的 研究在后循环动脉狭窄治疗中应用药物洗脱支架的安全性和疗效性.方法 经常规造影证实椎动脉狭窄者30例,接受支架置入治疗者19例.局麻或全麻下经右股动脉以Seldinger技术置入6 F导管鞘,在相应导丝辅助下使导引导管进入锁骨下动脉或椎动脉,血管造影后沿导引导管插入0.014英寸、300 cm或205 cm导丝至狭窄远端,经此微导丝交换置入相应规格球囊扩张式CypherTM支架(10例)或TAXUSTM支架(9例).结果 19例患者手术均成功,无死亡和并发症,置入支架贴壁良好,血流明显改善,狭窄远端分支血管(小脑后下动脉等)充盈明显改善,狭窄率由原来的平均87.5%降至平均5.2%.15例表现为眩晕症状的患者术后症状消失12例(80%),改善3例.表现为共济失调的6例患者术后共济运动基本正常4例,明显改善2例,表现为小脑性语言障碍的1例患者术后明显改善.完成至少1次造影随访的患者15例,经DSA证实无再狭窄发生.所有患者门诊随访,最长18个月.结论 药物洗脱支架在后循环动脉狭窄的治疗中安全、有效,在短期内能防止术后再狭窄,长期疗效需进一步观察,需要大样本的随机对照研究进一步证实.     

喜炎平注射液联合头孢呋辛钠治疗小儿肺炎的临床效果

目的：探讨喜炎平注射液联合头孢呋辛钠治疗小儿肺炎的疗效。方法：选取本院2013年1月-2014年7月收治的80例小儿肺炎患者作为研究对象,按照随机数字列表法将其分为研究组和对照组,每组40例。对照组单纯采用头孢呋辛钠进行治疗,研究组在对照组的治疗基础上联合喜炎平注射液进行治疗,7 d为一疗程。治疗1个疗程后,观察比较两组患儿的临床疗效、临床症状消失时间、住院天数及并发症发生情况。结果：经1个疗程的治疗后,研究组的治疗总有效率97.5%明显高于对照组的80.0%,且患儿发热症状、咳嗽及胸部湿啰音等临床症状消失时间及住院天数均明显短于对照组,差异均有统计学意义（P<0.05）。而两组患儿的并发症发生率比较差异无统计学意义（P>0.05）。结论：对小儿肺炎患者采用喜炎平注射液联合头孢呋辛钠进行治疗具有良好的临床疗效,患儿的症状消退时间和住院时间短,且不会增加并发症的发生率,值得在临床上进一步推广。     

参麦注射液含量测定方法的改进

目的:建立高效液相色谱法测定参麦注射液中人参皂苷Re含量的方法。方法:色谱柱:KromasilC18(250 mm×4.6 mm,5μm),流动相:乙腈-0.05%磷酸(15:85),检测波长:203 nm,流速为1 mL/min。结果:人参皂苷Re的回归方程为:Y=91273.9x+313 618г=0.999 8,(n=6)。线性范围为:52.46-314.76 mg/L,平均回收率为99.54%,RSD为0.38%(n=5)。结论:该方法具有简便、快速、准确,重现性好,与标准法比较无显著性差别,适合于参麦注射液含量的测定。     

Dynorphin-(1–13)-Like Immunoreactivity in Central Nervous System and Pituitary Gland of Spontaneously Hypertensive Rats

We determined by radioimmunoassay concentrations of dynorphin-(1–13)-like immunoreactivity in the central nervous system and pituitary gland of spontaneously hypertensive rats (SHRs) and normotensive Wistar-Kyoto rats (WKYs). Compared to WKYs, SHRs had significantly lower levels of dynorphin-(1–13)-like immunoreactivity in the hypothalamus and pituitary gland. However, such immunoreactivity in the cerebral cortex, caudate nucleus, diencephalon, brainstem and spinal cord of SHRs and WKYs were similar.     

肾康注射液治疗老年糖尿病肾病的临床观察

目的探讨肾康注射液治疗老年糖尿病肾病的疗效和安全性,为明确有效治疗老年糖尿病肾病的方法提供方法。方法选择2016年11月—2018年11月在武汉市中心医院肾内与风湿科治疗的老年糖尿病肾病患者112例,采用数字表法随机分为观察组(n=56)和对照组(n=56)。对照组给予常规治疗,观察组在与对照组相同的常规治疗基础上增加肾康注射液治疗,疗程均为28 d。评估并比较2组治疗前后肾功能水平、血糖水平、中医症状积分、临床疗效以及不良反应发生情况。结果治疗前,2组肌酐(Creatinine,Scr)、尿素氮(Blood urea nitrogen,BUN)、24 h尿蛋白、肌酐清除率(Creatinine clearance,Ccr)水平差异均无统计学意义(P>0.05)。治疗后,2组Scr、BUN、24 h尿蛋白水平均比治疗前显著下降,且观察组水平显著低于对照组,差异均有统计学意义(P<0.05)。治疗前,2组空腹血糖、血红蛋白(Hemoglobin,Hb)、白蛋白(Albumin,Alb)和血钙(Calcium,Ca)水平差异均无统计学意义(P>0.05)。治疗后,2组空腹血糖比治疗前均显著下降,且观察组水平显著低于对照组,差异均有统计学意义(P<0.05);Hb、Alb和Ca水平比治疗前均升高,且观察组患者Hb和Alb水平显著高于对照组,差异均有统计学意义(P<0.05)。治疗前,2组中医症状积分无显著差异(P>0.05)。治疗后,2组中医症状积分比治疗前均降低,且观察组积分显著低于对照组,差异均有统计学意义(P<0.05)。治疗结束后,观察组临床有效率显著高于对照组[96.43%(54/56)vs 73.21%(41/56),P<0.05)]。2组均未出现明显的不良反应。结论在常规西医治疗的基础上采用肾康注射液治疗老年糖尿病肾病,可显著改善患者的肾功能、血糖水平,显著提高临床疗效,且安全性较高,具有一定的临床应用价值。     

Endovascular treatment of posterior cerebral artery aneurysms using detachable coils

Introduction Aneurysms of the posterior cerebral artery (PCA) are rare, and most of the studies reported in the literature in which the endovascular approach was applied were carried out on a limited number of patients with PCA aneurysms. We retrospectively reviewed our cases of PCA aneurysms – at various locations and of differing shapes – that received endovascular treatment and evaluated the treatment outcome. Methods From January 1996 to December 2006, 13 patients (eight females and five males) with 17 PCA aneurysms (nine fusiform and eight saccular) were treated using the endovascular approach. The age of the patients ranged from 20 to 67 years, with a mean age of 44 years. Of the 13 patients, ten presented with intracranial hemorrhage, and one patient, with a large P2 aneurysm, presented with trigeminal neuralgia; the aneurysms were asymptomatic in the remaining two patients. Results All 13 patients were successfully treated, with only one procedure-related symptomatic complication. Seven patients were treated by occlusion of the aneurysm and parent artery together; five patients, by selective embolization of the aneurysm; one patient, by partial coiling. Although infarctions were found in two patients treated with selective embolization and in three patients treated with parent artery occlusion, only one patient with a ruptured P2 aneurysm treated with parent artery occlusion developed transient amnesia as an ischemic symptom. Conclusion Posterior cerebral artery aneurysms can be treated safely with either occlusion of the aneurysm together with the PCA or with a selective coil embolization. Infarctions may occur after endovascular treatment, but they are rarely the cause of a disabling symptom.     

血栓通冻干粉针剂治疗肾病综合征高凝及高脂状态的临床效果分析

目的探讨血栓通冻干粉针剂治疗肾病综合征高凝及高脂状态的临床效果。方法30例肾病综合征患者随机分为治疗组（16例）和对照组（14例）,在常规治疗的基础上,治疗组用血栓通冻干粉针剂150mg加入5%葡萄糖注射液100ml静脉滴注,每日1次抗凝、降脂治疗;对照组用低分子肝素钠抗凝、普伐他汀钠降脂治疗,连用4周,两组疗程相同。治疗前后检测凝血指标、血脂状况及其他生化指标。结果疗程结束后两组患者凝血指标、血脂状况与治疗前相比均有统计学意义,但两组间比较无统计学意义。结论血栓通冻干粉针剂应用治疗肾病综合征高凝及高脂状态是一种安全有效的抗凝、降脂治疗措施,且价格低廉,效果确切,值得在临床推广应用。